| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2029-02-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 550.00 |
| Coupon | 3.125 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 550 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Catalent Pharma Solutions, Inc. corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million USD and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Catalent Pharma Solutions, Inc., founded in 2007 and headquartered in Somerset, New Jersey, is a leading global provider of advanced drug delivery technologies, development, and manufacturing solutions for pharmaceuticals, biologics, and consumer health products. The company offers a range of services including formulation development, clinical trial materials, and commercial manufacturing, making it a crucial partner in the life sciences industry.